A New Self-Controlled Case Series Method for Analyzing Spontaneous Reports of Adverse Events After Vaccination

被引:10
|
作者
Escolano, S. [1 ,2 ]
Hill, C. [3 ]
Tubert-Bitter, P. [1 ,2 ]
机构
[1] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Biostat Team, F-94807 Villejuif, France
[2] Univ Paris 11, Unite Mixte Rech Sci 1018, Villejuif, France
[3] Inst Gustave Roussy, Biostat & Epidemiol Serv, Villejuif, France
关键词
adverse events; intussusception; pharmacoepidemiology; pharmacovigilance; rotavirus; self-controlled case series; spontaneous reporting; vaccines; IDIOPATHIC THROMBOCYTOPENIC PURPURA; SIGNAL-DETECTION METHODS; FALSE DISCOVERY RATES; ROTAVIRUS VACCINATION; RETROSPECTIVE EVALUATION; UNITED-KINGDOM; B VACCINE; PHARMACOVIGILANCE; SAFETY; DATABASE;
D O I
10.1093/aje/kwt128
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In this paper, we propose new methods for analyzing cases of vaccine adverse events spontaneously reported to a surveillance database. The methods use the self-controlled case series approach, extended in several ways with parametric and nonparametric assumptions to account for the specific features of the data (large amount of underreporting and variation of reporting with time since vaccination). This work was motivated by the documented risk of intussusception after RotaShield vaccination (Wyeth-Lederle Vaccines, Radnor, Pennsylvania) and used worldwide spontaneous reports of intussusception occurring after Rotarix vaccination (GlaxoSmithKline Biologics, Research Triangle Park, North Carolina) collected between January 2004 and February 2010. The estimated risk during the 3- to 7-day period after vaccination was approximately 5 times higher after dose 1 of Rotarix than after dose 2, which is similar to published findings on the same topic. We undertook a large simulation study to evaluate the performance of the method in different scenarios, including its robustness to different sample sizes and time-dependent reporting functions. The bias was generally small, the type I error rate was correctly controlled, and the power to detect a risk ratio of 4 was satisfactory, provided that the sample size was over 100. The proposed methods are an effective way to explore and quantify vaccine safety signals from spontaneous reports.
引用
收藏
页码:1496 / 1504
页数:9
相关论文
共 50 条
  • [21] Mortality and the self-controlled case series method: Letter to the Editor
    Farrington, Paddy
    Whitaker, Heather
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (08) : 906 - 906
  • [22] The self-controlled case series method for evaluating safety of vaccines
    Hawken, Steven
    Wilson, Kumanan R.
    MEDICAL JOURNAL OF AUSTRALIA, 2012, 197 (10) : 578 - 579
  • [23] Self-Controlled Case Series Methodology
    Whitaker, Heather J.
    Ghebremichael-Weldeselassie, Yonas
    ANNUAL REVIEW OF STATISTICS AND ITS APPLICATION, VOL 6, 2019, 6 : 241 - 261
  • [24] Spline-based self-controlled case series method
    Ghebremichael-Weldeselassie, Yonas
    Whitaker, Heather J.
    Farrington, C. Paddy
    STATISTICS IN MEDICINE, 2017, 36 (19) : 3022 - 3038
  • [25] Self-controlled case series method with smooth age effect
    Ghebremichael-Weldeselassie, Yonas
    Whitaker, Heather J.
    Farrington, C. Paddy
    STATISTICS IN MEDICINE, 2014, 33 (04) : 639 - 649
  • [26] The self-controlled case series method and covid-19
    Farrington, Paddy
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [27] Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study
    Xu, Stanley
    Sy, Lina S.
    Hong, Vennis
    Holmquist, Kimberly J.
    Qian, Lei
    Farrington, Paddy
    Bruxvoort, Katia J.
    Klein, Nicola P.
    Fireman, Bruce
    Han, Bing
    Lewin, Bruno J.
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2024, 10 : e53807
  • [28] Influenza vaccination and risk of stroke: Self-controlled case-series study
    Asghar, Zahid
    Coupland, Carol
    Siriwardena, Niroshan
    VACCINE, 2015, 33 (41) : 5458 - 5463
  • [29] COVID-19 vaccination and acute neurological events in England: A self-controlled case series using the openSAFELY platform
    Schultze, Anna
    Walker, Jemma
    Tazare, John R.
    Tamborska, Arina
    Singh, Bhagteshwar
    Donegan, Katherine
    Stowe, Julia
    Morton, Caroline
    Evans, Stephen
    Solomon, Tom
    Andrews, Nick
    Douglas, Ian
    Ben Goldacre
    Smeeth, Liam
    McDonald, Helen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 117 - 117
  • [30] Adverse Events following 12 and 18 Month Vaccinations: a Population-Based, Self-Controlled Case Series Analysis
    Wilson, Kumanan
    Hawken, Steven
    Kwong, Jeffrey C.
    Deeks, Shelley
    Crowcroft, Natasha S.
    Van Walraven, Carl
    Potter, Beth K.
    Chakraborty, Pranesh
    Keelan, Jennifer
    Pluscauskas, Michael
    Manuel, Doug
    PLOS ONE, 2011, 6 (12):